US2020368216A1PendingUtilityA1
Treatment of sunburn using analgesics and antihistamines
Assignee: SEPHORIS PHARMACEUTICALS LLCPriority: Oct 26, 2009Filed: Aug 14, 2020Published: Nov 26, 2020
Est. expiryOct 26, 2029(~3.3 yrs left)· nominal 20-yr term from priority
A61K 31/192A61K 31/4402A61K 31/444A61K 31/554A61K 31/5415A61K 31/435A61J 1/035A61K 45/06A61P 29/00A61P 17/02A61K 31/60A61K 31/495A61P 25/00A61P 37/08A61P 17/00A61K 31/135
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Combination compositions and kits comprising an analgesic and an antihistamine are provided as well as methods of use in treating sunburn.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A product for treatment of a sunburn in a subject in need thereof, the product comprising 3 to 40 oral dosage units, wherein each oral dosage unit comprises about 400 mg of ibuprofen, about 4 mg of chlorpheniramine, and a pharmaceutically acceptable excipient.
2 . The product of claim 1 , wherein the product comprises from 5 to 35 oral dosage units.
3 . The product of claim 1 , wherein the product comprises from 10 to 30 oral dosage units.
4 . The product of claim 1 , wherein the product comprises from 8 to 10 oral dosage units.
5 . The product of claim 1 , wherein the product comprises from 3 to 20 oral dosage units.
6 . The product of claim 1 , wherein the product comprises from 4 to 16 oral dosage units.
7 . The product of claim 1 , wherein the oral dosage unit is a solid or a liquid.
8 . The product of claim 1 , wherein the oral dosage unit is a tablet or a capsule.
9 . The product of claim 1 , wherein the oral dosage unit is free of an additional active agent.
10 . A product for treatment of a sunburn in a subject in need thereof, the product comprising 3 to 40 oral dosage units, wherein each oral dosage unit comprises about 200 mg to about 600 mg of ibuprofen, about 2 mg to about 6 mg of chlorpheniramine, and a pharmaceutically acceptable excipient.
11 . The product of claim 10 , wherein each oral dosage unit comprises about 200 mg, about 400 mg, or about 600 mg of ibuprofen; about 2 mg, about 4 mg, or about 6 mg of chlorpheniramine; and a pharmaceutically acceptable excipient.
12 . The product of claim 10 , wherein the product comprises from 5 to 35 oral dosage units.
13 . The product of claim 10 , wherein the product comprises from 10 to 30 oral dosage units.
14 . The product of claim 10 , wherein the product comprises from 8 to 10 oral dosage units.
15 . The product of claim 10 , wherein the product comprises from 3 to 20 oral dosage units.
16 . The product of claim 10 , wherein the product comprises from 4 to 16 oral dosage units.
17 . The product of claim 10 , wherein the oral dosage unit is a solid or a liquid.
18 . The product of claim 10 , wherein the oral dosage unit is a tablet or a capsule.
19 . The product of claim 10 , wherein each oral dosage unit is free of an additional active agent.
20 . A product for treatment of a sunburn in a subject in need thereof, the product comprising 3 to 40 oral dosage units, wherein each oral dosage unit comprises about 50 mg to about 800 mg of ibuprofen, about 1 mg to about 8 mg of chlorpheniramine, and a pharmaceutically acceptable excipient; and wherein each oral dosage unit is free of an additional active agent.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.